Anchor Capital Advisors LLC Biogen Inc. Transaction History

Anchor Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$219.29 - $241.72 $10.2 Million - $11.2 Million	-46,459 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $333,516 - $521,659	1,539 Added 3.43%	46,459 $11 Million
Q4 2018 Feb 04, 2019	SELL	$278.5 - $352.75 $306,628 - $388,377	-1,101 Reduced 2.39%	44,920 $13.5 Million
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $13.5 Million - $17.7 Million	46,021 New	46,021 $16.3 Million
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $1.55 Million - $1.84 Million	-6,000 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $1.56 Million - $2.21 Million	6,000 New	6,000 $1.64 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Anchor Capital Advisors LLC with notifications on news.